Dr. Wang Jian’s talk on Dec. 16th

Dec - 13
2011

Dr. Wang Jian’s talk on Dec. 16th

Dear HMS-CSSA members,

HMS-CSSA will hold a seminar on this friday (Dec.16th). The invited speaker is Dr. Wang Jian, the director and founder of Beijing Genomics Institute (BGI). As a well-respected researcher, Dr. Wang has made significant contributions in many fields. In the meantime, with his leadership, BGI has become the largest genomics center in the world. It is a great opportunity to share his interesting and valuable experience.

Here is the detail information for the talk
Time: 10am-11am, Dec 16th, friday
Location: Room 836AB, Jimmy fund building, Dana-Farber cancer institute,
44 binney str, Boston, 02115
(pizza and soft drink will be provided)

Below is the introduction of Dr. Wang Jian and BGI

Thank you and look forward to seeing you in the talk.

Best
HMS-CSSA

  

Dr. Jian Wang – Director and Founder, BGI

Dr. Jian Wang, founding visionary of BGI, is a well-respected research scientist internationally and an avid adventurer, having successfully climbed Mt. Everest. Dr. Wang has received multiple awards for his achievements, including the Qiu Shi Collective Award for Outstanding Achievement of Science & Technologies from the Qiu Shi Science and Technology Foundation, and the Collective Award for Outstanding Achievement of Science & Technologies from the Chinese Academy of Sciences. He also was recognized by Beijing as the Outstanding Individual in Prevention and Cure of SARS. Widely published in peer reviewed scientific publications such as Nature and Science, Dr. Wang’s current research interests include the development of genomic and bioinformatic applications in various fields. Prior to founding BGI, Dr. Wang was a senior research fellow at the University of Washington, where he served as one of the main leaders and decision-makers for genomic sequencing projects, and conducted postdoctoral research at the University of Texas and the University of Iowa.

BGI (formerly known as Beijing Genomics Institute) was founded in Beijing on Sept 9th, 1999 with the mission of supporting the development of science and technology, building strong research teams, and promoting the development of scientific partnership in genomics field.??With a goal toward excellence, high efficiency, and accuracy, BGI has successfully completed a large number of projects. These include sequencing 1% of the human genome for the International Human Genome Project, contributing 10% to the International Human HapMap Project, carrying out research to combat SARS, being a key player in the Sino-British Chicken Genome Project, and completely sequencing the rice genome, the silkworm genome, and, most recently, the first Asian diploid genome. Much of this research has been published in the top international academic journals Nature and Science, which witnessed the path of BGI from projects participation to leading the development of genomics. In conjunction with carrying out these projects, BGI has established its own technical platforms based on large-scale genome sequencing, efficient bioinformatics analyses, and innovative genetic health care initiatives. These distinguished achievements have made a great contribution to the development of genomics in both China and the world, and have established BGI as a world-class research institution. In the course of attaining these goals, BGI has undergone a historic breakthrough from the number one genomics institute in Asia to one of the leading genomics institutes in the world.

Throughout its short history, BGI has created an institutional structure that is characterized by systematization and innovation, institutional integration, technological platform development and product commercialization. This collaborative system, all of which is powered by the study of genomics, enables BGI to rapidly move from basic research to application. On April 27th, 2010, BGI Americas was founded and set up its main office in Boston, MA, U.S.A. BGI America offers scientific and technological collaboration and services to all countries in North, Central, and South America, provides R&D in technology and product development, and seeks opportunities of cooperative projects in the fields of sequencing and bioinformatics.